← FDA DRUG APPROVALS

FDA ANDA · ANDA088250

ANUSOL HC

hydrocortisone

Sponsor: SALIX PHARMS

APPLICATION
ANDA088250
TYPE
ANDA
ORIGINAL APPROVAL
1984-06-06
LATEST ACTION
2000-08-11
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

ANUSOL HCPrescription
HYDROCORTISONE 2.5% · CREAM · TOPICAL

Approval history

2000-08-11Manufacturing (CMC) · Supplement 8AP
2000-01-19Manufacturing (CMC) · Supplement 7AP
1998-12-07Manufacturing (CMC) · Supplement 6AP
1998-05-13Manufacturing (CMC) · Supplement 4AP
1998-05-13Manufacturing (CMC) · Supplement 5AP
1997-12-10Manufacturing (CMC) · Supplement 3AP
1993-05-19Labeling · Supplement 2AP
1985-03-06Manufacturing (CMC) · Supplement 1AP
1984-06-06OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →